A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors

NCT06796907 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

392

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumours, Gynecological

Interventions

DRUG: GSK5733584
DRUG: Dostarlimab
DRUG: Bevacizumab
DRUG: Anticancer therapy 3
DRUG: Anticancer therapy 4

Sponsor

GlaxoSmithKline